{"id": "chatcmpl-B2D26hG75GH6sr9JtnTBWz5CClOHG", "object": "chat.completion", "created": 1739866454, "model": "gpt-4o-mini-2024-07-18", "choices": [{"index": 0, "message": {"role": "assistant", "content": null, "function_call": {"name": "get_weaksignals", "arguments": "{\"signals\":[{\"name\":\"Rising Demand for Weight Loss Drugs\",\"description\":\"Sales of semaglutide surge, indicating a growing market for obesity treatments.\",\"change\":\"Change from limited acceptance of obesity drugs to widespread consumer demand and healthcare integration.\",\"10-year\":\"In 10 years, obesity drugs could be a standard and routine part of healthcare for weight management and diabetes.\",\"driving-force\":\"Increased awareness and acknowledgment of obesity as a major health issue motivating treatment.\",\"relevancy\":5},{\"name\":\"Household Recognition of Pharmaceutical Products\",\"description\":\"Celebrities and public figures openly using semaglutide raise its profile among consumers.\",\"change\":\"Change from pharmaceuticals being niche to becoming mainstream and widely discussed in daily life.\",\"10-year\":\"In 10 years, common pharmaceutical treatments may have the same cultural presence as lifestyle brands or diets.\",\"driving-force\":\"The influence of social media and celebrity endorsements on public health choices and trends.\",\"relevancy\":4},{\"name\":\"Supply Constraints in Pharmaceutical Industry\",\"description\":\"Novo Nordisk warns of supply limitations for semaglutide, highlighting a production bottleneck.\",\"change\":\"Change from steady production to challenges in meeting the rapidly increasing demand for obesity treatments.\",\"10-year\":\"In 10 years, there could be more regulated systems for scaling production of highly demanded pharmaceuticals.\",\"driving-force\":\"The balance between demand surges and production capabilities in the pharmaceutical sector.\",\"relevancy\":4},{\"name\":\"Regional Expansion of Drug Availability\",\"description\":\"Novo Nordisk launches semaglutide in various countries, reflecting a global health trend.\",\"change\":\"Change from localized drug markets to a more global distribution of effective obesity and diabetes treatments.\",\"10-year\":\"In 10 years, obesity treatments may be universally available, integrated into healthcare systems worldwide.\",\"driving-force\":\"Globalization and shared health challenges leading to collaborative healthcare strategies.\",\"relevancy\":4},{\"name\":\"Innovation in Obesity Treatment\",\"description\":\"Semaglutide represents a new class of pharmaceuticals for obesity with significant efficacy.\",\"change\":\"Change from traditional weight management options to innovative drug therapies offering notable weight loss results.\",\"10-year\":\"In 10 years, there could be more novel obesity treatments developed, being as common as metabolic drugs.\",\"driving-force\":\"The push for effective solutions to combat rising obesity rates globally.\",\"relevancy\":5}]}"}, "refusal": null}, "logprobs": null, "finish_reason": "function_call"}], "usage": {"prompt_tokens": 770, "completion_tokens": 479, "total_tokens": 1249, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_00428b782a"}